| NOSIX | VTSAX | NOSIX / VTSAX | |
| Total Expense Ratio | 0.05 | 0.04 | 125% |
| Annual Report Gross Expense Ratio | 0.10 | 0.04 | 250% |
| Fund Existence | 30 years | 26 years | - |
| Gain YTD | 10.125 | 9.883 | 102% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 3000 | 83% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 19.3B | 2.3T | 1% |
| Annual Yield % from dividends | 1.05 | 1.05 | 100% |
| Returns for 1 year | 17.39 | 18.52 | 94% |
| Returns for 3 years | 59.33 | 62.18 | 95% |
| Returns for 5 years | 62.49 | 63.13 | 99% |
| Returns for 10 years | 234.73 | 246.76 | 95% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GXXAX | 12.68 | 0.12 | +0.96% |
| abrdn US Sustainable Leaders A | |||
| HSVRX | 54.68 | 0.40 | +0.74% |
| Harbor Small Cap Value Admin | |||
| ALMRX | 29.61 | 0.07 | +0.24% |
| Alger Mid Cap Growth Institutional I | |||
| IAXSX | 9.86 | -0.03 | -0.30% |
| VY® T. Rowe Price Divers Mid Cap Gr S | |||
| THISX | 89.95 | -1.09 | -1.20% |
| T. Rowe Price Health Sciences I | |||